Little Rock, AR, United States of America

Xingui Liu

This inventor holds 2 USPTO granted patents. Top assignee: Bioventures, LLC. Active years: 2018-2020.


% Patents Active = 50.0

Average Co-Inventor Count = 8.0

ph-index = 1

Forward Citations = 7(Granted Patents)


Company Filing History:


Years Active: 2018-2020

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Innovations by Inventor Xingui Liu

Introduction

Xingui Liu is a notable inventor based in Little Rock, AR (US). He has made significant contributions to the field of aging and age-related disorders through his innovative research. With a total of 2 patents, Liu's work focuses on the selective depletion of senescent cells, which has implications for delaying aging and treating various age-related conditions.

Latest Patents

Liu's latest patents include compositions and methods for selectively depleting senescent cells. The first patent details a composition that comprises piperlongumine (PL) or a derivative thereof, aimed at selectively killing senescent cells. This innovative approach may help delay aging and treat age-related disorders. The second patent reiterates the same focus on the selective killing of senescent cells using piperlongumine, emphasizing its potential benefits in the field of gerontology.

Career Highlights

Xingui Liu is currently associated with Bioventures, LLC, where he continues to advance his research and innovations. His work has garnered attention for its potential to revolutionize treatments for aging and related health issues.

Collaborations

Liu collaborates with esteemed colleagues such as Guangrong Zheng and Daohong Zhou, contributing to a dynamic research environment that fosters innovation and discovery.

Conclusion

Xingui Liu's contributions to the field of aging through his innovative patents highlight the importance of research in improving health outcomes for aging populations. His work at Bioventures, LLC, along with his collaborations, positions him as a key figure in the ongoing quest to understand and combat age-related disorders.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…